(NASDAQ: LEGN) Legend Biotech's forecast annual revenue growth rate of 14.35% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 31.63%, and while it is forecast to beat the US market's average forecast revenue growth rate of 12.01%.
Legend Biotech's revenue in 2026 is $1,358,400,000.On average, 19 Wall Street analysts forecast LEGN's revenue for 2026 to be $565,613,652,114, with the lowest LEGN revenue forecast at $526,819,848,814, and the highest LEGN revenue forecast at $596,260,756,721. On average, 18 Wall Street analysts forecast LEGN's revenue for 2027 to be $683,546,814,146, with the lowest LEGN revenue forecast at $614,105,906,239, and the highest LEGN revenue forecast at $782,083,074,528.
In 2028, LEGN is forecast to generate $784,798,640,759 in revenue, with the lowest revenue forecast at $668,029,292,826 and the highest revenue forecast at $968,293,330,368.